Eric Raymond
Impact in
-
- Pancreatic and Hepatic Oncology Research
- Cancer Treatment and Pharmacology
- Drug Transport and Resistance Mechanisms
-
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 3
- Pancreatic and Hepatic Oncology Research 1
- Cancer Treatment and Pharmacology 1
- HER2/EGFR in Cancer Research 1
- Ear and Head Tumors 1
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Eric K. Rowinsky (1 shared paper)Gary M. Clark (1 shared paper)Elżbieta Izbicka (1 shared paper)Sandrine Faivre (3 shared papers)Daniel D. Von Hoff (1 shared paper)Axel R. Hanauske (1 shared paper)Olivier Hermine (1 shared paper)Jean‐François Seitz (1 shared paper)
In The Last Decade
Eric Raymond
4 papers receiving 104 citations
Peers
Comparison fields: 5 of 45
- Oncology 47
- Biomaterials 22
- Cancer Research 12
- Pharmaceutical Science 5
- Immunology 15
Countries citing papers authored by Eric Raymond
This map shows the geographic impact of Eric Raymond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Raymond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Raymond more than expected).
Fields of papers citing papers by Eric Raymond
This network shows the impact of papers produced by Eric Raymond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Raymond. The network helps show where Eric Raymond may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Raymond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 52 | |
| 2 | 1997 | 48 | |
| 3 | 2022 | 7 | |
| 4 | 2021 | 2 |
About Eric Raymond
Eric Raymond is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cell Biology and Hepatology, having authored 4 papers that have together received 109 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Liver physiology and pathology (1 paper), Microtubule and mitosis dynamics (1 paper), PI3K/AKT/mTOR signaling in cancer (1 paper), Cancer Treatment and Pharmacology (1 paper), HER2/EGFR in Cancer Research (1 paper) and Ear and Head Tumors (1 paper). The work is most often cited by research in Oncology (47 citations), Biomaterials (22 citations), Cancer Research (12 citations), Pharmaceutical Science (5 citations) and Immunology (15 citations). Eric Raymond has collaborated with scholars based in France, Italy and Germany. Frequent co-authors include Eric K. Rowinsky, Gary M. Clark, Elżbieta Izbicka, Sandrine Faivre, Daniel D. Von Hoff, Axel R. Hanauske, Olivier Hermine, Jean‐François Seitz, Jean‐Pierre Kinet and Emmanuel Mitry. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Cancers, British Journal of Cancer and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.